NasdaqGS - Nasdaq Real Time Price USD

Walgreens Boots Alliance, Inc. (WBA)

Compare
8.12 -0.11 (-1.40%)
As of 9:42 AM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Total Revenue
147,658,000.00
147,658,000.00
139,081,000.00
132,703,000.00
132,509,000.00
Cost of Revenue
121,134,000.00
121,134,000.00
112,009,000.00
104,437,000.00
104,442,000.00
Gross Profit
26,524,000.00
26,524,000.00
27,072,000.00
28,265,000.00
28,067,000.00
Operating Expense
28,113,000.00
28,113,000.00
34,205,000.00
27,295,000.00
24,586,000.00
Operating Income
-1,589,000.00
-1,589,000.00
-7,133,000.00
970,000.00
3,481,000.00
Net Non Operating Interest Income Expense
-482,000.00
-482,000.00
-580,000.00
-400,000.00
-905,000.00
Other Income Expense
-12,148,000.00
-12,148,000.00
2,295,000.00
3,416,000.00
-581,000.00
Pretax Income
-14,219,000.00
-14,219,000.00
-5,419,000.00
3,985,000.00
1,995,000.00
Tax Provision
1,246,000.00
1,246,000.00
-1,858,000.00
-30,000.00
667,000.00
Earnings from Equity Interest Net of Tax
17,000.00
17,000.00
33,000.00
50,000.00
627,000.00
Net Income Common Stockholders
-8,636,000.00
-8,636,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
Diluted NI Available to Com Stockholders
-8,636,000.00
-8,636,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
Basic EPS
-10.01
--
-3.57
5.02
2.94
Diluted EPS
-10.01
--
-3.57
5.01
2.93
Basic Average Shares
863,100.00
--
863,200.00
864,400.00
864,800.00
Diluted Average Shares
863,100.00
--
863,200.00
865,900.00
866,400.00
Total Operating Income as Reported
-14,076,000.00
-14,076,000.00
-6,882,000.00
1,387,000.00
2,342,000.00
Total Expenses
149,247,000.00
149,247,000.00
146,214,000.00
131,732,000.00
129,028,000.00
Net Income from Continuing & Discontinued Operation
-8,636,000.00
-8,636,000.00
-3,080,000.00
4,337,000.00
2,542,000.00
Normalized Income
1,397,790.00
1,397,790.00
-3,080,000.00
4,337,000.00
1,985,000.00
Interest Expense
482,000.00
482,000.00
580,000.00
400,000.00
905,000.00
Net Interest Income
-482,000.00
-482,000.00
-580,000.00
-400,000.00
-905,000.00
EBIT
-13,737,000.00
-13,737,000.00
-4,839,000.00
4,385,000.00
2,900,000.00
EBITDA
-11,278,000.00
-11,278,000.00
-2,582,000.00
6,375,000.00
4,873,000.00
Reconciled Cost of Revenue
121,134,000.00
121,134,000.00
112,009,000.00
104,437,000.00
104,442,000.00
Reconciled Depreciation
2,459,000.00
2,459,000.00
2,257,000.00
1,990,000.00
1,973,000.00
Net Income from Continuing Operation Net Minority Interest
-8,636,000.00
-8,636,000.00
-3,080,000.00
4,337,000.00
1,985,000.00
Total Unusual Items Excluding Goodwill
-12,701,000.00
-12,701,000.00
--
--
--
Total Unusual Items
-12,701,000.00
-12,701,000.00
--
--
--
Normalized EBITDA
1,423,000.00
1,423,000.00
-2,582,000.00
6,375,000.00
4,873,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,667,210.00
-2,667,210.00
--
--
--
8/31/2021 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PETS PetMed Express, Inc.
4.5600
-0.44%
 
HITI High Tide Inc.
2.6450
-0.56%
 
HITI.V High Tide Inc.
3.7000
-0.27%
 
PINK.PR Pilulka Lékárny a.s.
126.00
0.00%
 
CJJD China Jo-Jo Drugstores, Inc.
1.8500
-8.87%
 
BIMI BIMI Holdings Inc.
0.0100
0.00%
 
RADLY Raia Drogasil S.A.
5.0000
+14.42%
 
6618.HK JD Health International Inc.
28.600
-1.04%
 
PGMN3.SA Empreendimentos Pague Menos S.A.
3.2100
-1.83%
 
4164.SR Nahdi Medical Company
118.60
-1.00%